Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 52 studies | 49% ± 21% | |
fibroblast | 28 studies | 32% ± 14% | |
pericyte | 24 studies | 38% ± 20% | |
smooth muscle cell | 24 studies | 35% ± 13% | |
epithelial cell | 22 studies | 49% ± 22% | |
endothelial cell of lymphatic vessel | 20 studies | 38% ± 13% | |
basal cell | 20 studies | 48% ± 22% | |
capillary endothelial cell | 17 studies | 56% ± 15% | |
endothelial cell of artery | 15 studies | 74% ± 16% | |
vein endothelial cell | 15 studies | 52% ± 17% | |
mesothelial cell | 12 studies | 54% ± 18% | |
endothelial cell of vascular tree | 12 studies | 43% ± 16% | |
type I pneumocyte | 11 studies | 54% ± 16% | |
secretory cell | 11 studies | 47% ± 20% | |
type II pneumocyte | 10 studies | 44% ± 16% | |
myofibroblast cell | 10 studies | 47% ± 25% | |
connective tissue cell | 10 studies | 45% ± 21% | |
ciliated cell | 10 studies | 43% ± 24% | |
club cell | 9 studies | 45% ± 24% | |
enterocyte | 8 studies | 38% ± 15% | |
goblet cell | 8 studies | 38% ± 12% | |
progenitor cell | 7 studies | 45% ± 21% | |
respiratory goblet cell | 6 studies | 36% ± 13% | |
abnormal cell | 6 studies | 25% ± 11% | |
classical monocyte | 5 studies | 28% ± 3% | |
enteroendocrine cell | 5 studies | 40% ± 10% | |
intestinal crypt stem cell | 5 studies | 30% ± 13% | |
transit amplifying cell | 5 studies | 29% ± 6% | |
astrocyte | 5 studies | 31% ± 12% | |
conventional dendritic cell | 4 studies | 25% ± 8% | |
glomerular endothelial cell | 4 studies | 78% ± 8% | |
monocyte | 4 studies | 19% ± 3% | |
neuron | 4 studies | 37% ± 10% | |
luminal cell of prostate epithelium | 4 studies | 36% ± 10% | |
duct epithelial cell | 3 studies | 31% ± 3% | |
hillock cell | 3 studies | 51% ± 9% | |
squamous epithelial cell | 3 studies | 44% ± 17% | |
T cell | 3 studies | 48% ± 26% | |
adventitial cell | 3 studies | 16% ± 1% | |
serous secreting cell | 3 studies | 34% ± 5% | |
endocardial cell | 3 studies | 56% ± 7% | |
endothelial cell of sinusoid | 3 studies | 64% ± 29% | |
dendritic cell | 3 studies | 24% ± 8% | |
keratinocyte | 3 studies | 33% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 98% | 8638.04 | 1414 / 1445 | 93% | 286.12 | 171 / 183 |
thymus | 100% | 12164.49 | 651 / 653 | 91% | 383.66 | 549 / 605 |
bladder | 95% | 15234.10 | 20 / 21 | 91% | 614.85 | 461 / 504 |
stomach | 94% | 5521.19 | 336 / 359 | 89% | 342.85 | 254 / 286 |
lung | 98% | 9353.27 | 566 / 578 | 78% | 188.24 | 904 / 1155 |
intestine | 84% | 4487.49 | 813 / 966 | 90% | 395.52 | 472 / 527 |
uterus | 75% | 3475.98 | 127 / 170 | 91% | 518.63 | 417 / 459 |
prostate | 97% | 8657.53 | 237 / 245 | 62% | 122.18 | 310 / 502 |
kidney | 94% | 4630.04 | 84 / 89 | 63% | 143.08 | 565 / 901 |
brain | 61% | 1360.71 | 1622 / 2642 | 90% | 199.34 | 635 / 705 |
adrenal gland | 94% | 3584.23 | 242 / 258 | 38% | 60.85 | 87 / 230 |
pancreas | 38% | 645.82 | 124 / 328 | 90% | 272.34 | 160 / 178 |
liver | 73% | 3275.46 | 166 / 226 | 32% | 56.23 | 129 / 406 |
breast | 88% | 5775.25 | 404 / 459 | 16% | 16.62 | 174 / 1118 |
ovary | 64% | 2604.17 | 115 / 180 | 38% | 59.60 | 164 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 916.72 | 1 / 1 |
heart | 98% | 6211.93 | 847 / 861 | 0% | 0 | 0 / 0 |
skin | 82% | 4277.73 | 1490 / 1809 | 11% | 19.68 | 52 / 472 |
tonsil | 0% | 0 | 0 / 0 | 93% | 382.52 | 42 / 45 |
blood vessel | 93% | 5384.66 | 1237 / 1335 | 0% | 0 | 0 / 0 |
spleen | 92% | 3326.52 | 221 / 241 | 0% | 0 | 0 / 0 |
adipose | 90% | 6532.23 | 1081 / 1204 | 0% | 0 | 0 / 0 |
muscle | 22% | 442.30 | 180 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 18.42 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043534 | Biological process | blood vessel endothelial cell migration |
GO_0010621 | Biological process | negative regulation of transcription by transcription factor localization |
GO_0001525 | Biological process | angiogenesis |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0048514 | Biological process | blood vessel morphogenesis |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0030154 | Biological process | cell differentiation |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0140110 | Molecular function | transcription regulator activity |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ID1 |
Protein name | DNA-binding protein inhibitor ID-1 (Class B basic helix-loop-helix protein 24) (bHLHb24) (Inhibitor of DNA binding 1) (Inhibitor of differentiation 1) |
Synonyms | BHLHB24 ID |
Description | FUNCTION: Transcriptional regulator (lacking a basic DNA binding domain) which negatively regulates the basic helix-loop-helix (bHLH) transcription factors by forming heterodimers and inhibiting their DNA binding and transcriptional activity. Implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation. Inhibits skeletal muscle and cardiac myocyte differentiation. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer (By similarity). . |
Accessions | ENST00000376105.4 [P41134-2] P41134 ENST00000376112.4 [P41134-1] |